Advances in Whole Genome Sequencing Technology
Keywords: Arabidopsis; Chromatin-immunopreci-pitation; Complete Genomics; DNA synthesis; Genome; HapMap project; Helicos Biosciences; Il-lumina's Genome Analyzer (GA); Ion Torrent; Mycoplasma genitalia; Pacific Biosciences; Pi-coTiterPlate (PTP); RainDance Technologies; True Single Molecule Se-quencing (tSMS); applications; asthma; chemiluminescent detection; clonal bridge-amplification; combinatorial probe-anchor ligation (cPAL) technology; dideoxynucleotide triphos-phates (ddNTPs); epigenetics; fluorescent dyes; fluorophore; genome wide association studies; hybridization; inflammatory bowel disease; intron-exon boundary; luciferase; megagenomics; next generation sequencing (NGS); nucleotide complementary; oligonucleotides; phosphodiester bond; phosphor-linked nucleotides; photolithographically etched pat-terned array; polymerase; polystyrene; prostate cancer; sequencing; silicon dioxide; single nucleotide flow; single stranded DNA; sulphurylase; technology; tran-scriptome sequencing (RNA-seq); transcriptome sequencing; triphosphates; zero-mode waveguides
Document Type: Research Article
Publication date: 01 February 2011
- Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content